124 related articles for article (PubMed ID: 196022)
1. Cyclic nucleotide changes in human neutrophils induced by chemoattractants and chemotactic modulators.
Hatch GE; Nichols WK; Hill HR
J Immunol; 1977 Aug; 119(2):450-6. PubMed ID: 196022
[No Abstract] [Full Text] [Related]
2. Relationships between chemotaxis, chemotactic modulators, and cyclic nucleotide levels in tumor cells.
Mokashi S; Delikatny SJ; Orr FW
Cancer Res; 1983 May; 43(5):1980-3. PubMed ID: 6299536
[TBL] [Abstract][Full Text] [Related]
3. Induction of a transient elevation in intracellular levels of adenosine-3',5'-cyclic monophosphate by chemotactic factors: an early event in human neutrophil activation.
Simchowitz L; Fischbein LC; Spilberg I; Atkinson JP
J Immunol; 1980 Mar; 124(3):1482-91. PubMed ID: 6153685
[No Abstract] [Full Text] [Related]
4. Effect of cyclic adenosine 3',5'-monophosphate antagonists on endotoxin-induced inhibition of human neutrophil chemotaxis.
Issekutz AC; Ng M; Biggar WD
Infect Immun; 1979 May; 24(2):434-40. PubMed ID: 222686
[TBL] [Abstract][Full Text] [Related]
5. Chemokinetic and chemotactic activity of various prostaglandins for neutrophil granulocytes.
Till G; Kownatzki E; Seitz M; Gemsa D
Clin Immunol Immunopathol; 1979 Jan; 12(1):111-8. PubMed ID: 217564
[No Abstract] [Full Text] [Related]
6. Role of cyclic nucleotides in the proliferation of committed granulocyte-macrophage progenitor cells.
Kurland JI; Hadden JW; Moore MA
Cancer Res; 1977 Dec; 37(12):4534-8. PubMed ID: 200354
[No Abstract] [Full Text] [Related]
7. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
Meeker RB; Harden TK
Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
[TBL] [Abstract][Full Text] [Related]
8. [Drug-induced changes in chemotaxis under normal conditions and in rheumatoid arthritis].
Berti C; Pellegrini R; Lalumera M; Morozzi G; Marcolongo R
Boll Soc Ital Biol Sper; 1982 Apr; 58(7):378-84. PubMed ID: 6282290
[TBL] [Abstract][Full Text] [Related]
9. Cyclic nucleotides regulate the morphologic alterations required for chemotaxis in monocytes.
Stephens CG; Snyderman R
J Immunol; 1982 Mar; 128(3):1192-7. PubMed ID: 6120193
[TBL] [Abstract][Full Text] [Related]
10. Proceedings: Variations in cGMP and cAMP levels in rat uterine smooth muscle induced by carbachol, PGF2alpha and changes in ionic composition.
d'Auriac GA; Worcel M
Br J Pharmacol; 1975 Jun; 54(2):236P-237P. PubMed ID: 167895
[No Abstract] [Full Text] [Related]
11. Relationship between the prostaglandin system and responsiveness to epileptogenic agents in mature and immature rats.
Paoletti R; Folco GC; Spagnuolo C; Terzi C
Adv Prostaglandin Thromboxane Res; 1978; 4():191-8. PubMed ID: 206121
[No Abstract] [Full Text] [Related]
12. The role of cyclic GMP in the action of carbamylcholine on the cycli AMP level in the dog thyroid.
Champion S; Jacquemin C
FEBS Lett; 1978 Aug; 92(2):156-8. PubMed ID: 212294
[No Abstract] [Full Text] [Related]
13. Modulation of human neutrophil chemotactic responses by cyclic 3',5'-guanosine monophosphate and cyclic 3',5'-adenosine monophosphate.
Hill HR; Estensen RD; Quie PG; Hogan NA; Goldberg ND
Metabolism; 1975 Mar; 24(3):447-56. PubMed ID: 165364
[TBL] [Abstract][Full Text] [Related]
14. Cyclic nucleotides in immune responses and allergy.
Plaut M; Marone G; Thomas LL; Lichtenstein LM
Adv Cyclic Nucleotide Res; 1980; 12():161-72. PubMed ID: 6157314
[No Abstract] [Full Text] [Related]
15. Modulation of polymorphonuclear leukocyte-mediated antibody-dependent cellular cytotoxicity.
Gale RP; Zighelboim J
J Immunol; 1974 Dec; 113(6):1793-800. PubMed ID: 4372270
[No Abstract] [Full Text] [Related]
16. Enhancement of neutrophil chemotaxis and alteration of levels of cellular cyclic nucleotides by levamisole.
Hogan NA; Hill HR
J Infect Dis; 1978 Oct; 138(4):437-44. PubMed ID: 213494
[TBL] [Abstract][Full Text] [Related]
17. Dual effects of formylpeptides on the adhesion of endotoxin-primed human neutrophils.
Bellavite P; Chirumbolo S; Lippi G; Andrioli G; Bonazzi L; Ferro I
Cell Biochem Funct; 1993 Dec; 11(4):231-9. PubMed ID: 7903912
[TBL] [Abstract][Full Text] [Related]
18. The potentiating effect of an alpha-adrenergic blocking agent (E-643) on the action of bronchodilators.
Kitamura S; Ishihara Y; Yotsumoto H; Kosaka K
Arzneimittelforschung; 1980; 30(1):37-40. PubMed ID: 6102862
[TBL] [Abstract][Full Text] [Related]
19. Effects of levamisole on normal and abnormal leukocyte locomotion.
Wright DG; Kirkpatrick CH; Gallin JI
J Clin Invest; 1977 May; 59(5):941-50. PubMed ID: 192765
[TBL] [Abstract][Full Text] [Related]
20. Ceramide selectively inhibits calcium-mediated potentiation of beta-adrenergic-stimulated cyclic nucleotide accumulation in rat pinealocytes.
Negishi T; Chik CL; Ho AK
Biochem Biophys Res Commun; 1998 Mar; 244(1):57-61. PubMed ID: 9514888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
